JPH09309856A - Aqueous solution of formaldehyde - Google Patents
Aqueous solution of formaldehydeInfo
- Publication number
- JPH09309856A JPH09309856A JP12706696A JP12706696A JPH09309856A JP H09309856 A JPH09309856 A JP H09309856A JP 12706696 A JP12706696 A JP 12706696A JP 12706696 A JP12706696 A JP 12706696A JP H09309856 A JPH09309856 A JP H09309856A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- aqueous solution
- formaldehyde
- weight
- organic mono
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 title claims abstract description 195
- 239000007864 aqueous solution Substances 0.000 title claims abstract description 63
- 239000002253 acid Substances 0.000 claims abstract description 39
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract description 12
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 10
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 7
- 235000004279 alanine Nutrition 0.000 claims abstract description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000008729 phenylalanine Nutrition 0.000 claims abstract description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 5
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 5
- -1 amino, carboxyl Chemical group 0.000 claims abstract description 5
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 5
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004310 lactic acid Substances 0.000 claims abstract description 5
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 5
- 239000001630 malic acid Substances 0.000 claims abstract description 5
- 235000011090 malic acid Nutrition 0.000 claims abstract description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 5
- 235000004400 serine Nutrition 0.000 claims abstract description 5
- 125000001424 substituent group Chemical group 0.000 claims abstract description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 4
- 239000004471 Glycine Substances 0.000 claims abstract description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 3
- CGJMROBVSBIBKP-UHFFFAOYSA-N malonamic acid Chemical compound NC(=O)CC(O)=O CGJMROBVSBIBKP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000001931 aliphatic group Chemical group 0.000 claims abstract 2
- 239000008098 formaldehyde solution Substances 0.000 claims description 33
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 12
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 10
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 108010008488 Glycylglycine Proteins 0.000 claims description 5
- 229940043257 glycylglycine Drugs 0.000 claims description 5
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 229940024606 amino acid Drugs 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- FSQQTNAZHBEJLS-UPHRSURJSA-N maleamic acid Chemical compound NC(=O)\C=C/C(O)=O FSQQTNAZHBEJLS-UPHRSURJSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 4
- 239000011976 maleic acid Substances 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- ZAUCKOVBDQVTPE-UHFFFAOYSA-N 2-methylcyclohex-2-ene-1,1-dicarboxylic acid Chemical compound CC1=CCCCC1(C(O)=O)C(O)=O ZAUCKOVBDQVTPE-UHFFFAOYSA-N 0.000 claims description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 3
- JDVPQXZIJDEHAN-UHFFFAOYSA-N succinamic acid Chemical compound NC(=O)CCC(O)=O JDVPQXZIJDEHAN-UHFFFAOYSA-N 0.000 claims description 3
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- NOIZJQMZRULFFO-UHFFFAOYSA-N adipamic acid Chemical compound NC(=O)CCCCC(O)=O NOIZJQMZRULFFO-UHFFFAOYSA-N 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 claims description 2
- GTFMAONWNTUZEW-UHFFFAOYSA-N glutaramic acid Chemical compound NC(=O)CCCC(O)=O GTFMAONWNTUZEW-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960002510 mandelic acid Drugs 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 abstract description 6
- 239000003381 stabilizer Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000006076 specific stabilizer Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 81
- 235000019256 formaldehyde Nutrition 0.000 description 46
- 239000000203 mixture Substances 0.000 description 40
- 238000009472 formulation Methods 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- 229920002866 paraformaldehyde Polymers 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229940000635 beta-alanine Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical group 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- XTDYIOOONNVFMA-UHFFFAOYSA-N dimethyl pentanedioate Chemical compound COC(=O)CCCC(=O)OC XTDYIOOONNVFMA-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- CKFGINPQOCXMAZ-UHFFFAOYSA-N methanediol Chemical compound OCO CKFGINPQOCXMAZ-UHFFFAOYSA-N 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 238000005705 Cannizzaro reaction Methods 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】この発明は、ホルムアルデヒ
ド水溶液に関する。さらに詳しくは、この発明は、貯蔵
中における濁りもしくは沈澱生成が防止されたホルムア
ルデヒド水溶液に関する。TECHNICAL FIELD The present invention relates to an aqueous formaldehyde solution. More specifically, the present invention relates to an aqueous formaldehyde solution in which turbidity or precipitate formation during storage is prevented.
【0002】[0002]
【従来の技術】ホルムアルデヒドは一般的に37重量%
のホルムアルデヒド水溶液として市販されている。この
ホルムアルデヒドは水溶液中では大部分が水和し、メチ
レングリコール及び低級ポリオキシメチレングリコール
の平衡混合物として存在する。この平衡はホルムアルデ
ヒド濃度が高くなるにしたがって高重合度側に移動し、
高重合度成分は水に不溶のパラホルムアルデヒドとして
沈澱する。このパラホルムアルデヒドの析出はホルムア
ルデヒド水溶液の濁りもしくは沈澱の原因となり、著し
い場合には水溶液全体が固化することもある。また、ホ
ルムアルデヒド水溶液は、その温度が低くなるにしたが
ってポリオキシメチレングリコール溶解度が低下し、パ
ラホルムアルデヒドの沈殿が析出する。このようにホル
ムアルデヒド水溶液は安定性に乏しく、その取扱いは非
常に困難である。また、この濁りもしくは沈澱は、装置
・配管等の閉塞の原因になる。更に近年、40〜50重
量%の高濃度ホルムアルデヒド水溶液が工業的に使用さ
れるに至り、前記問題解決が切実に求められている。Formaldehyde is generally 37% by weight.
Is commercially available as an aqueous formaldehyde solution. This formaldehyde is predominantly hydrated in aqueous solution and exists as an equilibrium mixture of methylene glycol and lower polyoxymethylene glycol. This equilibrium moves to the higher polymerization side as the formaldehyde concentration increases,
The high degree of polymerization component precipitates as paraformaldehyde insoluble in water. The precipitation of paraformaldehyde causes turbidity or precipitation of the aqueous formaldehyde solution, and in the extreme case, the entire aqueous solution may solidify. In addition, as the temperature of the formaldehyde aqueous solution becomes lower, the solubility of polyoxymethylene glycol decreases, and the paraformaldehyde precipitates. Thus, the aqueous formaldehyde solution has poor stability and its handling is very difficult. In addition, this turbidity or precipitation causes blockage of the device, piping and the like. Further, in recent years, 40 to 50% by weight of high-concentration formaldehyde aqueous solution has been industrially used, and there is an urgent need for solving the above problems.
【0003】そこで、このようなホルムアルデヒド水溶
液貯蔵中におけるパラホルムアルデヒドの沈澱生成を防
止するために、ホルムアルデヒド水溶液中のメタノール
含有率及び貯蔵温度を高くすると共に、種々の添加剤を
添加する方法が開示されている(特公昭57-61009号公
報、特公昭62-41593号公報、特開平4-330030号公報、特
開平4-330031号公報、特公平8-2824号公報、特公平8-28
25号公報参照)。Therefore, in order to prevent the precipitation of paraformaldehyde during the storage of such formaldehyde aqueous solution, a method of increasing the methanol content in the formaldehyde aqueous solution and the storage temperature and adding various additives is disclosed. (JP-B-57-61009, JP-B-62-41593, JP-A-4-330030, JP-A-4-330031, JP-B-8-2824, JP-B-8-28)
(See Japanese Patent No. 25).
【0004】[0004]
【発明が解決しようとする課題】近年、ホルムアルデヒ
ド水溶液について、コスト低減の追求等による経済的な
理由や樹脂合成等における反応時間の短縮あるいは工業
廃水処理負荷の低減の追求等の使用上の理由により、メ
タノール含有率を低減させることが望まれている。この
低メタノール含有ホルムアルデヒド水溶液を安定化する
ためには、安定剤の添加量を増やし、かつ貯蔵温度を高
くする必要がある。しかしながら、貯蔵温度を高くする
と、カニッツァロ反応により蟻酸が生成して腐食の問題
が生じる。In recent years, aqueous solution of formaldehyde has been economically used due to the pursuit of cost reduction, or due to use reasons such as shortened reaction time in resin synthesis or reduction of industrial wastewater treatment load. It is desired to reduce the methanol content rate. In order to stabilize the low methanol content formaldehyde aqueous solution, it is necessary to increase the amount of the stabilizer added and to increase the storage temperature. However, when the storage temperature is increased, the Cannizzaro reaction produces formic acid, which causes a corrosion problem.
【0005】[0005]
【課題を解決するための手段】この発明の発明者らは、
安定なホルムアルデヒド水溶液を得るために鋭意研究し
た結果、低添加量であるにもかかわらず顕著な安定効
果、即ちメタノール含有率が低くても貯蔵温度を高くす
る必要がなく、しかもその安定効果が持続して得られる
安定化剤を見出し、この発明を完成させるに至った。SUMMARY OF THE INVENTION The inventors of the present invention have
As a result of diligent research to obtain a stable aqueous formaldehyde solution, a remarkable stabilizing effect despite the low addition amount, that is, it is not necessary to raise the storage temperature even if the methanol content is low, and the stabilizing effect is sustained. The present invention was completed by finding a stabilizer obtained by the above.
【0006】かくしてこの発明によれば、ホルムアルデ
ヒド水溶液に、一般式(I): R−COOH (I) (式中、Rは水酸基、アミノ基、カルボキシル基、イミ
ダゾリル基及びカルバモイル基から選択された少なくと
も1つの置換分を有する炭素数2〜10の脂肪族炭化水
素残基、もしくは任意に水酸基、アミノ基及びカルボキ
シル基から選択された少なくとも1つの置換分を有して
いてもよい炭素数6〜12の環状炭化水素残基又は窒素
含有6員複素環残基)で表される有機モノ又はポリカル
ボン酸を添加してなる安定なホルムアルデヒド水溶液が
提供される。Thus, according to the present invention, the aqueous formaldehyde solution has the general formula (I): R-COOH (I) (wherein R is at least a hydroxyl group, an amino group, a carboxyl group, an imidazolyl group and a carbamoyl group). An aliphatic hydrocarbon residue having 2 to 10 carbon atoms having one substituent, or 6 to 12 carbon atoms optionally having at least one substituent selected from a hydroxyl group, an amino group and a carboxyl group. A stable formaldehyde aqueous solution obtained by adding an organic mono- or polycarboxylic acid represented by the cyclic hydrocarbon residue or the nitrogen-containing 6-membered heterocyclic residue of
【0007】[0007]
【発明の実施の形態】この発明の安定なホルムアルデヒ
ド水溶液に添加される一般式(I)の有機モノ又はポリ
カルボン酸は、有機モノ、ジ又はトリカルボン酸が好ま
しい。また、式中、脂肪族炭化水素残基は、飽和又は不
飽和で、かつ直鎖状、分枝状又は環状の脂肪族炭化水素
残基を表す。BEST MODE FOR CARRYING OUT THE INVENTION The organic mono- or polycarboxylic acid of the general formula (I) added to the stable aqueous formaldehyde solution of the present invention is preferably an organic mono-, di- or tricarboxylic acid. In addition, in the formula, the aliphatic hydrocarbon residue represents a saturated or unsaturated, linear, branched, or cyclic aliphatic hydrocarbon residue.
【0008】一般式(I)で表される化合物の具体例と
しては、グリシン、グリシルグリシン、アラニン、β−
アラニン、バリン、ロイシン、イソロイシン及びピペリ
ジン酸等のアミノ酸類;安息香酸及びニコチン酸等の環
状カルボン酸類;マロン酸、コハク酸、グルタル酸、ア
ジピン酸及びマレイン酸等のジカルボン酸類;グリコー
ル酸、乳酸、グリセリン酸、α−オキシ酪酸及びヒドロ
アクリル酸等のオキシ酸類;アスパラギン酸及びグルタ
ミン酸等のモノアミノジカルボン酸類;セリン及びトレ
オニン等のオキシアミノ酸類;フェニルアラニン、ヒス
チジン、アントラニル酸及びp−アミノ安息香酸等の環
状アミノ酸類;フタル酸及びメチル−シクロヘキセン−
ジカルボン酸等の環状ジカルボン酸類;リンゴ酸、酒石
酸及びクエン酸等のオキシジカルボン酸類;サリチル酸
及びマンデル酸等の環状オキシ酸類;マロン酸モノアミ
ド、コハク酸モノアミド、グルタル酸モノアミド、アジ
ピン酸モノアミド及びマレイン酸モノアミド等のモノア
ミドカルボン酸類等が挙げられる。また、これらの化合
物は2種以上併用してもよい。Specific examples of the compound represented by the general formula (I) include glycine, glycylglycine, alanine and β-.
Amino acids such as alanine, valine, leucine, isoleucine and piperidic acid; cyclic carboxylic acids such as benzoic acid and nicotinic acid; dicarboxylic acids such as malonic acid, succinic acid, glutaric acid, adipic acid and maleic acid; glycolic acid, lactic acid, Oxyacids such as glyceric acid, α-oxybutyric acid and hydroacrylic acid; monoaminodicarboxylic acids such as aspartic acid and glutamic acid; oxyamino acids such as serine and threonine; phenylalanine, histidine, anthranilic acid and p-aminobenzoic acid Cyclic amino acids; phthalic acid and methyl-cyclohexene-
Cyclic dicarboxylic acids such as dicarboxylic acids; oxydicarboxylic acids such as malic acid, tartaric acid and citric acid; cyclic oxyacids such as salicylic acid and mandelic acid; malonic acid monoamide, succinic acid monoamide, glutaric acid monoamide, adipic acid monoamide and maleic acid monoamide And other monoamidocarboxylic acids. Also, two or more of these compounds may be used in combination.
【0009】上記化合物の中で、グリシルグリシン、ア
ラニン、β−アラニン、安息香酸、ニコチン酸、グルタ
ル酸、グリコール酸、乳酸、アスパラギン酸、グルタミ
ン酸、セリン、フェニルアラニン、フタル酸、メチル−
シクロヘキセン−ジカルボン酸、リンゴ酸、サリチル
酸、マレイン酸及びマレイン酸モノアミドが好ましく、
グリコール酸及びグリシルグリシンがより好ましい。Among the above compounds, glycylglycine, alanine, β-alanine, benzoic acid, nicotinic acid, glutaric acid, glycolic acid, lactic acid, aspartic acid, glutamic acid, serine, phenylalanine, phthalic acid, methyl-
Cyclohexene-dicarboxylic acid, malic acid, salicylic acid, maleic acid and maleic acid monoamide are preferred,
Glycolic acid and glycylglycine are more preferred.
【0010】ホルムアルデヒド水溶液の濁りもしくは沈
殿を抑制するために必要なこの発明の有機モノ又はポリ
カルボン酸の添加量(有効添加量)は、ホルムアルデヒ
ド水溶液の濃度、pH及び温度等により適宜決定するこ
とができる。例えば、ホルムアルデヒド水溶液は、濃度
が低い程、pHが低い程、また温度が高い程、安定な傾
向にある。このことから、安定度が高ければ有機モノ又
はポリカルボン酸の添加量をより低減することができ
る。一般に有機モノ又はポリカルボン酸の添加量は、ホ
ルムアルデヒド1モルに対して0.0001〜0.1モ
ル、好ましくは0.001〜0.01モルとすることが
できる。添加量が前記範囲であれば、有機モノ又はポリ
カルボン酸がホルムアルデヒド水溶液に溶解し易く、ま
た十分な安定効果が得られる。The addition amount (effective addition amount) of the organic mono- or polycarboxylic acid of the present invention necessary for suppressing the turbidity or precipitation of the formaldehyde aqueous solution can be appropriately determined depending on the concentration, pH and temperature of the formaldehyde aqueous solution. it can. For example, the aqueous formaldehyde solution tends to be stable as the concentration becomes lower, the pH becomes lower, and the temperature becomes higher. Therefore, if the stability is high, the addition amount of the organic mono- or polycarboxylic acid can be further reduced. Generally, the addition amount of the organic mono- or polycarboxylic acid can be 0.0001 to 0.1 mol, preferably 0.001 to 0.01 mol, relative to 1 mol of formaldehyde. When the amount added is within the above range, the organic mono- or polycarboxylic acid is easily dissolved in the aqueous formaldehyde solution, and a sufficient stabilizing effect can be obtained.
【0011】この発明の有機モノ又はポリカルボン酸の
添加対象となるホルムアルデヒド水溶液は、ホルムアル
デヒドの由来や生成過程等により、メチラール、メタノ
ール、ジメチルエーテル、蟻酸、蟻酸メチル、トリオキ
サン等の化合物を含んでいても差し支えない。The aqueous formaldehyde solution to which the organic mono- or polycarboxylic acid of the present invention is added may contain a compound such as methylal, methanol, dimethyl ether, formic acid, methyl formate, or trioxane depending on the origin of the formaldehyde or the production process. It doesn't matter.
【0012】[0012]
【実施例】この発明を以下の製剤例及び試験例により例
示するが、これらの例示はこの発明の範囲を限定するも
のではない。 製剤例1 50重量%ホルムアルデヒド水溶液 99.9重量部 β−アラニン 0.1重量部 製剤例2 50重量%ホルムアルデヒド水溶液 99.9重量部 安息香酸 0.1重量部 製剤例3 50重量%ホルムアルデヒド水溶液 99.9重量部 ニコチン酸 0.1重量部 製剤例4 50重量%ホルムアルデヒド水溶液 99.9重量部 グリコール酸 0.1重量部 製剤例5 50重量%ホルムアルデヒド水溶液 99.9重量部 アスパラギン酸 0.1重量部The present invention is illustrated by the following formulation examples and test examples, but these exemplifications do not limit the scope of the present invention. Formulation Example 1 50 wt% formaldehyde aqueous solution 99.9 parts by weight β-alanine 0.1 part by weight Formulation Example 2 50 wt% formaldehyde aqueous solution 99.9 parts by weight Benzoic acid 0.1 part by weight Formulation Example 3 50 wt% formaldehyde aqueous solution 99 9.9 parts by weight Nicotinic acid 0.1 parts by weight Formulation example 4 50% by weight aqueous formaldehyde solution 99.9 parts by weight Glycolic acid 0.1 parts by weight Formulation example 5 50% by weight aqueous formaldehyde solution 99.9 parts by weight Aspartic acid 0.1 parts by weight Department
【0013】製剤例6 50重量%ホルムアルデヒド水溶液 99.9重量部 メチル−シクロヘキセン−ジカルボン酸 0.1重量部 製剤例7 50重量%ホルムアルデヒド水溶液 99.9重量部 マレイン酸 0.1重量部 製剤例8 50重量%ホルムアルデヒド水溶液 99.9重量部 マレイン酸モノアミド 0.1重量部 製剤例9 50重量%ホルムアルデヒド水溶液 99.9重量部 グリシルグリシン 0.1重量部 製剤例10 50重量%ホルムアルデヒド水溶液 98.9重量部 アラニン 0.1重量部 メタノール 1.0重量部Formulation Example 6 50% by weight formaldehyde aqueous solution 99.9 parts by weight Methyl-cyclohexene-dicarboxylic acid 0.1 parts by weight Formulation Example 7 50% by weight formaldehyde aqueous solution 99.9 parts by weight Maleic acid 0.1 parts by weight Formulation Example 8 50 wt% formaldehyde aqueous solution 99.9 parts by weight Maleic acid monoamide 0.1 part by weight Formulation example 9 50% by weight formaldehyde aqueous solution 99.9 parts by weight Glycylglycine 0.1 part by weight Formulation example 10 50% by weight formaldehyde aqueous solution 98.9 Parts by weight alanine 0.1 parts by weight methanol 1.0 parts by weight
【0014】製剤例11 50重量%ホルムアルデヒド水溶液 98.9重量部 ニコチン酸 0.1重量部 メタノール 1.0重量部 製剤例12 50重量%ホルムアルデヒド水溶液 98.9重量部 グルタル酸 0.1重量部 メタノール 1.0重量部 製剤例13 50重量%ホルムアルデヒド水溶液 98.9重量部 乳酸 0.1重量部 メタノール 1.0重量部 製剤例14 50重量%ホルムアルデヒド水溶液 98.9重量部 グルタミン酸 0.1重量部 メタノール 1.0重量部 製剤例15 50重量%ホルムアルデヒド水溶液 98.9重量部 セリン 0.1重量部 メタノール 1.0重量部Formulation Example 11 50 wt% formaldehyde aqueous solution 98.9 parts by weight Nicotinic acid 0.1 part by weight Methanol 1.0 part by weight Formulation Example 12 50% by weight formaldehyde aqueous solution 98.9 parts by weight Glutaric acid 0.1 part by weight Methanol 1.0 parts by weight Formulation Example 13 50% by weight aqueous formaldehyde solution 98.9 parts by weight Lactic acid 0.1 parts by weight Methanol 1.0 parts by weight Formulation Example 14 50% by weight aqueous formaldehyde solution 98.9 parts by weight Glutamic acid 0.1 parts by weight methanol 1.0 parts by weight Formulation Example 15 50% by weight aqueous formaldehyde solution 98.9 parts by weight Serine 0.1 parts by weight Methanol 1.0 parts by weight
【0015】製剤例16 50重量%ホルムアルデヒド水溶液 98.9重量部 フェニルアラニン 0.1重量部 メタノール 1.0重量部 製剤例17 50重量%ホルムアルデヒド水溶液 98.9重量部 フタル酸 0.1重量部 メタノール 1.0重量部 製剤例18 50重量%ホルムアルデヒド水溶液 98.9重量部 リンゴ酸 0.1重量部 メタノール 1.0重量部 製剤例19 50重量%ホルムアルデヒド水溶液 98.9重量部 サリチル酸 0.1重量部 メタノール 1.0重量部 製剤例20 50重量%ホルムアルデヒド水溶液 94.9重量部 ニコチン酸 0.09重量部 フェニルアラニン 0.01重量部 メタノール 5.0重量部Formulation Example 16 50 wt% formaldehyde aqueous solution 98.9 parts by weight Phenylalanine 0.1 part by weight methanol 1.0 part by weight Formulation Example 17 50% by weight formaldehyde aqueous solution 98.9 parts by weight phthalic acid 0.1 part by weight methanol 1 0.0 parts by weight Formulation Example 18 50% by weight aqueous formaldehyde solution 98.9 parts by weight Malic acid 0.1 parts by weight Methanol 1.0 parts by weight Formulation Example 19 50% by weight aqueous formaldehyde solution 98.9 parts by weight Salicylic acid 0.1 parts by weight methanol 1.0 parts by weight Formulation Example 20 50% by weight aqueous formaldehyde solution 94.9 parts by weight Nicotinic acid 0.09 parts by weight Phenylalanine 0.01 parts by weight Methanol 5.0 parts by weight
【0016】比較製剤例1 50重量%ホルムアルデヒド水溶液 99.0重量部 メタノール 1.0重量部 比較製剤例2 50重量%ホルムアルデヒド水溶液 95.0重量部 メタノール 5.0重量部 比較製剤例3 50重量%ホルムアルデヒド水溶液 99.9重量部 エチレングリコール 0.1重量部 比較製剤例4 50重量%ホルムアルデヒド水溶液 99.9重量部 トリエチレングリコール 0.1重量部 比較製剤例5 50重量%ホルムアルデヒド水溶液 99.9重量部 プロピオンアミド 0.1重量部Comparative formulation example 1 50% by weight aqueous formaldehyde solution 99.0 parts by weight methanol 1.0 part by weight Comparative formulation example 2 50% by weight aqueous formaldehyde solution 95.0 parts by weight Methanol 5.0 parts by weight Comparative formulation example 3 50% by weight Aqueous formaldehyde solution 99.9 parts by weight Ethylene glycol 0.1 part by weight Comparative formulation example 4 50% by weight formaldehyde aqueous solution 99.9 parts by weight Triethylene glycol 0.1 part by weight Comparative formulation example 5 50% by weight formaldehyde aqueous solution 99.9 parts by weight Propionamide 0.1 part by weight
【0017】比較製剤例6 50重量%ホルムアルデヒド水溶液 99.9重量部 スクシンアミド酸 0.1重量部 比較製剤例7 50重量%ホルムアルデヒド水溶液 99.9重量部 グルタル酸ジメチル 0.1重量部 比較製剤例8 50重量%ホルムアルデヒド水溶液 99.9重量部 アセチルアセトン 0.1重量部 比較製剤例9 50重量%ホルムアルデヒド水溶液 98.9重量部 アセチルアセトン 0.1重量部 メタノール 1.0重量部 比較製剤例10 50重量%ホルムアルデヒド水溶液 98.9重量部 プロピオン酸 0.1重量部 メタノール 1.0重量部Comparative Formulation Example 6 50% by weight aqueous formaldehyde solution 99.9 parts by weight Succinamic acid 0.1 parts by weight Comparative formulation example 7 50% by weight aqueous formaldehyde solution 99.9 parts by weight Dimethyl glutarate 0.1 parts by weight Comparative formulation example 8 50 wt% formaldehyde aqueous solution 99.9 parts by weight acetylacetone 0.1 part by weight Comparative formulation example 9 50% by weight aqueous formaldehyde solution 98.9 parts by weight acetylacetone 0.1 part by weight methanol 1.0 part by weight Comparative formulation example 10 50% by weight formaldehyde Aqueous solution 98.9 parts by weight Propionic acid 0.1 parts by weight Methanol 1.0 parts by weight
【0018】比較製剤例11 50重量%ホルムアルデヒド水溶液 98.9重量部 ソルビン酸 0.1重量部 メタノール 1.0重量部 比較製剤例12 50重量%ホルムアルデヒド水溶液 98.9重量部 オレイン酸 0.1重量部 メタノール 1.0重量部 比較製剤例13 50重量%ホルムアルデヒド水溶液 98.9重量部 グルタル酸ジメチル 0.1重量部 メタノール 1.0重量部 比較製剤例14 50重量%ホルムアルデヒド水溶液 98.9重量部 スクシンアミド酸 0.1重量部 メタノール 1.0重量部 比較製剤例15 50重量%ホルムアルデヒド水溶液 98.9重量部 エチレングリコール 0.1重量部 メタノール 1.0重量部Comparative formulation example 11 50% by weight formaldehyde aqueous solution 98.9 parts by weight sorbic acid 0.1 part by weight methanol 1.0 part by weight Comparative formulation example 12 50% by weight formaldehyde aqueous solution 98.9 parts by weight oleic acid 0.1 part by weight Parts Methanol 1.0 parts by weight Comparative Preparation Example 13 50% by weight aqueous formaldehyde solution 98.9 parts by weight Dimethyl glutarate 0.1 parts by weight Methanol 1.0 parts by weight Comparative Preparation Example 14 50% by weight aqueous formaldehyde solution 98.9 parts by weight Succinamide Acid 0.1 parts by weight Methanol 1.0 parts by weight Comparative Preparation Example 15 50% by weight aqueous formaldehyde solution 98.9 parts by weight Ethylene glycol 0.1 parts by weight Methanol 1.0 parts by weight
【0019】試験例1〔50重量%ホルムアルデヒド水
溶液の50℃での安定性確認試験〕 製剤例1〜9及び比較製剤例1〜8のホルムアルデヒド
水溶液製剤について50℃での安定性を経過日数ごとに
確認した。評価基準は次のように規定した。 ○:ホルムアルデヒド水溶液中に沈殿物なし △:ホルムアルデヒド水溶液がわずかに白濁 ×:ホルムアルデヒド水溶液中に沈殿物生成 その結果を表1に示す。Test Example 1 [Stability Confirmation Test of 50% by Weight Formaldehyde Aqueous Solution at 50 ° C.] With respect to the formaldehyde aqueous solution formulations of Formulation Examples 1 to 9 and Comparative Formulation Examples 1 to 8, stability at 50 ° C. was measured every several days. confirmed. The evaluation criteria are defined as follows. ◯: No precipitate in the formaldehyde aqueous solution Δ: Slight turbidity of the formaldehyde aqueous solution ×: Formation of precipitate in the formaldehyde aqueous solution The results are shown in Table 1.
【0020】[0020]
【表1】 [Table 1]
【0021】表1より、有機モノ又はポリカルボン酸の
添加が、ホルムアルデヒド水溶液の安定化に効果のある
ことが認められる。It can be seen from Table 1 that the addition of the organic mono- or polycarboxylic acid is effective in stabilizing the aqueous formaldehyde solution.
【0022】試験例2〔50重量%ホルムアルデヒド水
溶液の50℃での安定性確認試験〕 製剤例10〜19及び比較製剤例9〜15のメタノール
1%(製剤例19のみ5%)含有ホルムアルデヒド水溶
液について50℃での安定性を経過日数ごとに確認し
た。評価基準は試験例1と同様とした。その結果を表2
に示す。Test Example 2 [Stability Confirmation Test of 50% by Weight Formaldehyde Aqueous Solution at 50 ° C.] Formaldehyde aqueous solutions containing 1% of methanol (5% only in Formulation Example 19) of Formulation Examples 10 to 19 and Comparative Formulation Examples 9 to 15 The stability at 50 ° C was confirmed every several days. The evaluation criteria were the same as in Test Example 1. The results are shown in Table 2.
Shown in
【0023】[0023]
【表2】 [Table 2]
【0024】表2より、有機モノ又はポリカルボン酸の
添加が、メタノールを少量含有するホルムアルデヒド水
溶液の安定化に効果のあることがわかる。It can be seen from Table 2 that the addition of the organic mono- or polycarboxylic acid is effective in stabilizing the aqueous formaldehyde solution containing a small amount of methanol.
【0025】試験例3〔ホルムアルデヒド水溶液の濃
度、pH及び温度変化による安定性確認試験〕 パラホルムアルデヒド及び水を80℃で混合攪拌し、所
定濃度のホルムアルデヒド水溶液を得、これにそれぞれ
少量の水酸化ナトリウムまたは塩酸を添加し、所定のp
Hに調整した。次いでこの水溶液を所定温度まで冷却
し、供試試料を得た。得られた供試試料に、有機モノ又
はポリカルボン酸としてβ−アラニンを各濃度で添加
し、沈殿生成または白濁に要した日数を確認した。その
結果を表3に示す。Test Example 3 [Stability Confirmation Test by Concentration, pH and Temperature Change of Formaldehyde Aqueous Solution] Paraformaldehyde and water were mixed and stirred at 80 ° C. to obtain an aqueous formaldehyde solution having a predetermined concentration, and a small amount of sodium hydroxide was added to each. Or add hydrochloric acid
Adjusted to H. Then, this aqueous solution was cooled to a predetermined temperature to obtain a test sample. Β-Alanine as an organic mono- or polycarboxylic acid was added to the obtained test sample at each concentration, and the number of days required for precipitation or clouding was confirmed. Table 3 shows the results.
【0026】[0026]
【表3】 [Table 3]
【0027】表3より、ホルムアルデヒド水溶液の濃度
が低いほど、pHが低いほど、また温度が高いほど水溶
液は安定な傾向にあり、有機モノ又はポリカルボン酸の
添加量が少量であっても、水溶液が安定化していること
がわかる。From Table 3, the lower the concentration of the formaldehyde aqueous solution, the lower the pH, and the higher the temperature, the more stable the aqueous solution is. Even if the addition amount of the organic mono- or polycarboxylic acid is small, the aqueous solution tends to be stable. It can be seen that is stabilized.
【0028】[0028]
【発明の効果】この発明は、ホルムアルデヒド水溶液
に、有機モノ又はポリカルボン酸を安定有効量添加する
ことにより、その添加量が少量であるにもかかわらず、
ホルムアルデヒド水溶液の濁りもしくは沈殿を著しく抑
制し、安定なホルムアルデヒド水溶液を提供することが
できる。特に、従来の添加剤を添加したホルムアルデヒ
ド水溶液に比べて安定であり、貯蔵温度に関係なく、持
続的に安定なホルムアルデヒド水溶液を提供することが
できる。EFFECTS OF THE INVENTION The present invention adds a stable and effective amount of organic mono- or polycarboxylic acid to an aqueous formaldehyde solution, so that the addition amount is small,
A stable formaldehyde aqueous solution can be provided by significantly suppressing turbidity or precipitation of the formaldehyde aqueous solution. In particular, it is possible to provide a formaldehyde aqueous solution that is more stable than a conventional formaldehyde aqueous solution to which additives are added and that is stable regardless of the storage temperature.
Claims (13)
(I): R−COOH (I) (式中、Rは水酸基、アミノ基、カルボキシル基、イミ
ダゾリル基及びカルバモイル基から選択された少なくと
も1つの置換分を有する炭素数2〜10の脂肪族炭化水
素残基、もしくは任意に水酸基、アミノ基及びカルボキ
シル基から選択された少なくとも1つの置換分を有して
いてもよい炭素数6〜12の環状炭化水素残基又は窒素
含有6員複素環残基)で表される有機モノ又はポリカル
ボン酸を添加してなる安定なホルムアルデヒド水溶液。1. An aqueous formaldehyde solution containing at least one substituent selected from the general formula (I): R—COOH (I) (wherein R is a hydroxyl group, an amino group, a carboxyl group, an imidazolyl group, and a carbamoyl group). An aliphatic hydrocarbon residue having 2 to 10 carbon atoms, or a cyclic hydrocarbon residue having 6 to 12 carbon atoms, which may optionally have at least one substituent selected from a hydroxyl group, an amino group and a carboxyl group. A stable formaldehyde aqueous solution obtained by adding an organic mono- or polycarboxylic acid represented by a group or a nitrogen-containing 6-membered heterocyclic residue).
ン酸が、グリシン、グリシルグリシン、アラニン、β−
アラニン、バリン、ロイシン、イソロイシン及びピベリ
ジン酸から1種以上選択されたアミノ酸である請求項1
記載の水溶液。2. The organic mono- or polycarboxylic acid of general formula (I) is glycine, glycylglycine, alanine, β-
The amino acid selected from at least one of alanine, valine, leucine, isoleucine and piberidic acid.
The aqueous solution described.
ン酸が、安息香酸及びニコチン酸から1種以上選択され
た環状カルボン酸である請求項1記載の水溶液。3. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is a cyclic carboxylic acid selected from one or more kinds of benzoic acid and nicotinic acid.
ン酸が、マロン酸、コハク酸、グルタル酸、アジピン酸
及びマレイン酸から1種以上選択されたジカルボン酸で
ある請求項1記載の水溶液。4. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is a dicarboxylic acid selected from at least one of malonic acid, succinic acid, glutaric acid, adipic acid and maleic acid. .
ン酸が、グリコール酸、乳酸、グリセリン酸、α−オキ
シ酪酸及びヒドロアクリル酸から1種以上選択されたオ
キシ酸である請求項1記載の水溶液。5. The organic mono- or polycarboxylic acid of general formula (I) is an oxy acid selected from one or more of glycolic acid, lactic acid, glyceric acid, α-oxybutyric acid and hydroacrylic acid. Aqueous solution.
ン酸が、アスパラギン酸及びグルタミン酸から1種以上
選択されたモノアミノジカルボン酸である請求項1記載
の水溶液。6. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is a monoaminodicarboxylic acid selected from at least one of aspartic acid and glutamic acid.
ン酸が、セリン及びトレオニンから1種以上選択された
オキシアミノ酸である請求項1記載の水溶液。7. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is an oxyamino acid selected from one or more kinds of serine and threonine.
ン酸が、フェニルアラニン、ヒスチジン、アントラニル
酸及びp−アミノ安息香酸から1種以上選択された環状
アミノ酸である請求項1記載の水溶液。8. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is a cyclic amino acid selected from one or more selected from phenylalanine, histidine, anthranilic acid and p-aminobenzoic acid.
ン酸が、フタル酸、及びメチル−シクロヘキセン−ジカ
ルボン酸から1種以上選択された環状ジカルボン酸であ
る請求項1記載の水溶液。9. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid represented by the general formula (I) is a cyclic dicarboxylic acid selected from one or more of phthalic acid and methyl-cyclohexene-dicarboxylic acid.
ボン酸が、リンゴ酸、酒石酸及びクエン酸から1種以上
選択されたオキシジカルボン酸である請求項1記載の水
溶液。10. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is an oxydicarboxylic acid selected from one or more kinds of malic acid, tartaric acid and citric acid.
ボン酸が、サリチル酸及びマンデル酸から1種以上選択
された環状オキシ酸である請求項1記載の水溶液。11. The aqueous solution according to claim 1, wherein the organic mono- or polycarboxylic acid of the general formula (I) is a cyclic oxy acid selected from at least one of salicylic acid and mandelic acid.
ボン酸が、マロン酸モノアミド、コハク酸モノアミド、
グルタル酸モノアミド、アジピン酸モノアミド及びマレ
イン酸モノアミドから1種以上選択されたモノアミドカ
ルボン酸である請求項1記載の水溶液。12. The organic mono- or polycarboxylic acid of general formula (I) is malonic acid monoamide, succinic acid monoamide,
The aqueous solution according to claim 1, which is a monoamide carboxylic acid selected from one or more of glutaric acid monoamide, adipic acid monoamide and maleic acid monoamide.
ボン酸が、ホルムアルデヒド1モルに対して0.000
1〜0.1モル含まれる請求項1〜12のいずれか1つ
に記載のホルムアルデヒド水溶液。13. The organic mono- or polycarboxylic acid represented by the general formula (I) is 0.000 with respect to 1 mol of formaldehyde.
The formaldehyde aqueous solution according to any one of claims 1 to 12, which is contained in an amount of 1 to 0.1 mol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12706696A JPH09309856A (en) | 1996-05-22 | 1996-05-22 | Aqueous solution of formaldehyde |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12706696A JPH09309856A (en) | 1996-05-22 | 1996-05-22 | Aqueous solution of formaldehyde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09309856A true JPH09309856A (en) | 1997-12-02 |
Family
ID=14950748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12706696A Pending JPH09309856A (en) | 1996-05-22 | 1996-05-22 | Aqueous solution of formaldehyde |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH09309856A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11349546A (en) * | 1998-05-14 | 1999-12-21 | Dsm Fine Chem Austria Gmbh | Stabilization of cyanohydrin |
-
1996
- 1996-05-22 JP JP12706696A patent/JPH09309856A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11349546A (en) * | 1998-05-14 | 1999-12-21 | Dsm Fine Chem Austria Gmbh | Stabilization of cyanohydrin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2375904C (en) | Treatment of aqueous aldehyde waste streams | |
| JP7159871B2 (en) | Deodorants | |
| US3527609A (en) | In-service cleaning of cooling water systems | |
| TW486362B (en) | Antibacterial composition | |
| EP4015596B1 (en) | Novel coolants with improved storage stability | |
| EP0845018A1 (en) | Use as antifreeze of polymers with recurring succinyl units | |
| JPH09309856A (en) | Aqueous solution of formaldehyde | |
| US4041232A (en) | Amphotericin B methyl ester salts | |
| US20060261313A1 (en) | Cerium ion-containing solution and corrosion inhibitor | |
| EP0603811B1 (en) | Boiler water treatment composition | |
| KR102380459B1 (en) | Water-based organic solderability preservative, and electronic board and surface treatment method using the same | |
| US5912389A (en) | Stabilizer and stabilizing method for aqueous aliphatic aldehyde solution | |
| US6784313B2 (en) | Process for producing carboxylic acids | |
| JPH1087580A (en) | Stabilized monoaminocarboxylic acids | |
| FI109332B (en) | Soluble compositions of toremifene | |
| US5371287A (en) | Releasably bound hydroxycarboxylic acids | |
| EP0157435A2 (en) | Aqueous aminomethylenephosphonic acid solutions containing organic carboxylate stabilizing agent | |
| US6054411A (en) | Cyanamide aqueous solution | |
| JP2904940B2 (en) | Improved formaldehyde reaction method | |
| USRE29981E (en) | Process for preparation of organic carboxylic acids | |
| US5021598A (en) | Process for making bismuth carboxylates | |
| US20020038863A1 (en) | Brine fluids with improved corrosion properties | |
| EP1038936B1 (en) | Brine fluids with improved corrosion properties | |
| JP3254246B2 (en) | Aqueous solution or slurry of iminocarboxylate and method of handling the same | |
| JP4024929B2 (en) | Etherification reaction method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060418 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060822 |